Stay updated with breaking news from Michael Chu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Canada is considering allowing patients to receive two different types of Covid-19 vaccines as the country deals with shortages of shots from AstraZeneca Plc and Moderna Inc.
Canada’s Vaccine Push Plagued by Confusion, Erratic Supply Bloomberg 1 hr ago Danielle Bochove and Kait Bolongaro (Bloomberg) -- Canada is considering allowing patients to receive two different types of Covid-19 vaccines as the country deals with shortages of shots from AstraZeneca Plc and Moderna Inc. Popular Searches Federal health officials are closely watching a U.K.-based trial in which participants received two kinds of shots. Results are expected in the next month or so, Supriya Sharma, chief medical adviser at Health Canada, said Wednesday at a news conference. Vac...
A Brand new Redondo Beach SHARE Mayor Bill Brand at the AES power plant in Dec. 2016. Brand had recently enlisted the support of Los Angeles County Supervisor Janice Hahn and State Assemblyman Al Muratsuchi in converting the AES power plant into a park. Photo by Brad Jacobson Slow growth Mayor Bill Brand has big plans for the power plant, the waterfront, and the Galleria by Ralph Doyle Redondo Beach has long been overshadowed by its smaller, but wealthier neighboring beach cities, Hermosa Beach and Manhattan Beach. Redondo Beach Mayor Bill Brand appears intent on changing that, base...
Date Time Innovative cancer therapy uses immune system to attack tumours Imagine if you could re-engineer your immune system to target and attack cancer growing in your body. A new clinical trial led by a clinician researcher at the University of Alberta is doing just that. Michael Chu, an assistant professor of oncology in the Faculty of Medicine & Dentistry, is leading a project to manufacture and test locally produced chimeric antigen receptor (CAR) T-cells for the treatment of leukemia and lymphoma. CAR T-cell therapy is an innovative treatment that uses a patient’s own immune system to...
Jeff from the Overwatch team has left the Overwatch team (and Blizzard) Jeff Kaplan, best known as the director of Overwatch, is leaving Blizzard after 19 years with the company. Aaron Keller, an 18-year Blizzard dev who’s worked on Overwatch from the beginning, will take over as director on both Overwatch and Overwatch 2. Additional news on both games is coming soon, Aaron Keller says in the announcement that Overwatch 2 “development is continuing at a good pace. We have an exceptional vision we’re executing on, the reaction from many of you to the updates we shared at BlizzConline thr...